Literature DB >> 30241939

YY1-induced upregulation of lncRNA KCNQ1OT1 regulates angiotensin II-induced atrial fibrillation by modulating miR-384b/CACNA1C axis.

Caijie Shen1, Bin Kong1, Yu Liu1, Liang Xiong1, Wei Shuai1, Guangji Wang1, Dajun Quan1, He Huang2.   

Abstract

Recent years, the role of long non-coding RNAs (lncRNAs) in atrial fibrillation (AF) has been gradually elucidated. In the current study, we measured the expression of ten AF-related lncRNAs to do qRT-PCR analysis. LncRNA KCNQ1 overlapping transcript 1 (KCNQ1OT1) was found to be significantly upregulated in AF model and Ang-II-induced mice heart. CACNA1C has been reported as a biomarker in atrial fibrillation. Here, we found that the expression pattern of CACNA1C was consistent with that of KCNQ1OT1. Electrophysiological study was conducted to demonstrate the effect of KCNQ1OT1 and CACNA1C on the Effective refractory period (ERP), interatrial conduction time (IACT), incidence of AF and AF duration of Ang-II-induced mice heart. Mechanically, KCNQ1OT1 contributed to the upregulation of CACNA1C by binding with miR-384. Furthermore, YY1 could activate the transcription of KCNQ1OT1 and CACNA1C. In conclusion, the present study revealed that YY1-induced upregulation of lncRNA KCNQ1OT1 regulates angiotensin II-induced atrial fibrillation by regulating miR-384/CACNA1C axis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; CACNA1C; KCNQ1OT1; YY1; miR-384

Mesh:

Substances:

Year:  2018        PMID: 30241939     DOI: 10.1016/j.bbrc.2018.09.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  miR-455-5p regulates atrial fibrillation by targeting suppressor of cytokines signaling 3.

Authors:  Weiling Li; Na Qi; Shuo Wang; Wenyan Jiang; Tao Liu
Journal:  J Physiol Biochem       Date:  2021-04-01       Impact factor: 4.158

2.  Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.

Authors:  Wei Wang; Shuai Han; Wei Gao; Yuan Feng; Kunhang Li; Di Wu
Journal:  Cell Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.046

3.  LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1.

Authors:  Qi-Hua Chen; Bo Li; De-Guo Liu; Biao Zhang; Xian Yang; Ya-Ling Tu
Journal:  Cancer Cell Int       Date:  2020-08-15       Impact factor: 5.722

Review 4.  Research Progress of LncRNAs in Atrial Fibrillation.

Authors:  Wenhui Wang; Bei Tian; Zhongping Ning; Xinming Li
Journal:  Mol Biotechnol       Date:  2022-02-02       Impact factor: 2.695

Review 5.  Transcriptional factors in calcium mishandling and atrial fibrillation development.

Authors:  Wenli Dai; Sneha Kesaraju; Christopher R Weber
Journal:  Pflugers Arch       Date:  2021-05-18       Impact factor: 4.458

6.  SNHG1-miR-186-5p-YY1 feedback loop alleviates hepatic ischemia/reperfusion injury.

Authors:  Qiang Sun; Jinlong Gong; Jianlong Wu; Zhipeng Hu; Qiao Zhang; Xiaofeng Zhu
Journal:  Cell Cycle       Date:  2022-03-11       Impact factor: 5.173

7.  Long noncoding RNA in cardiac aging and disease.

Authors:  Noelia Lozano-Vidal; Diewertje I Bink; Reinier A Boon
Journal:  J Mol Cell Biol       Date:  2019-10-25       Impact factor: 6.216

Review 8.  Role of Non-Coding Variants in Brugada Syndrome.

Authors:  Adrian Pérez-Agustín; Mel Lina Pinsach-Abuin; Sara Pagans
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

Review 9.  Long Non-Coding RNAs in Atrial Fibrillation: Pluripotent Stem Cell-Derived Cardiomyocytes as a Model System.

Authors:  Emre Bektik; Douglas B Cowan; Da-Zhi Wang
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

Review 10.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.